Evotec AG Company Profile (NASDAQ:EVTCY)

About Evotec AG (NASDAQ:EVTCY)

Evotec AG logoEvotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.

Industry, Sector and Symbol: Average Prices:
  • 50 Day Moving Avg: $30.71
  • 200 Day Moving Avg: $22.61
  • 52 Week Range: $8.78 - $33.13
P/E:
  • Trailing P/E Ratio: 48.97
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $203.35 million
  • Price / Sales: N/A
  • Book Value: $5.13 per share
  • Price / Book: 5.56
Profitability:
  • EBIDTA: $46.81 million
Misc:
  • Average Volume: 3,273 shs.
  • Short Ratio: 0.62
 
Frequently Asked Questions for Evotec AG (NASDAQ:EVTCY)

What is Evotec AG's stock symbol?

Evotec AG trades on the NASDAQ under the ticker symbol "EVTCY."

Who are some of Evotec AG's key competitors?

Who are Evotec AG's key executives?

Evotec AG's management team includes the folowing people:

  • Wolfgang Plischke, Chairman of the Supervisory Board
  • Werner Lanthaler, Chief Executive Officer, Member of the Management Board
  • Bernd Hirsch, Vice Chairman of the Supervisory Board
  • Enno Spillner, Chief Financial Officer, Member of the Management Board
  • Mario Polywka, Chief Operating Officer, Member of the Management Board
  • Cord Dohrmann, Chief Scientific Officer, Member of the Management Board
  • Claus T. Braestrup M.D., Member of the Supervisory Board
  • Paul L. Herrling Ph.D., Member of the Supervisory Board
  • Iris Loew-Friedrich, Member of the Supervisory Board
  • Elaine Sullivan, Member of the Supervisory Board

How do I buy Evotec AG stock?

Shares of Evotec AG can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Evotec AG's stock price today?

One share of Evotec AG stock can currently be purchased for approximately $28.50.


MarketBeat Community Rating for Evotec AG (NASDAQ EVTCY)
Community Ranking:  2.4 out of 5 ( )
Outperform Votes:  43 (Vote Outperform)
Underperform Votes:  45 (Vote Underperform)
Total Votes:  88
MarketBeat's community ratings are surveys of what our community members think about Evotec AG and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Evotec AG (NASDAQ:EVTCY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 2 Hold Ratings
Consensus Rating:Hold (Score: 1.67)
Consensus Price Target: N/A

Analysts' Ratings History for Evotec AG (NASDAQ:EVTCY)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/12/2017DZ Bank AGReiterated RatingSellMediumView Rating Details
6/6/2017Berenberg BankDowngradeBuy -> HoldLowView Rating Details
5/3/2017Deutsche Bank AGReiterated RatingNeutralLowView Rating Details
(Data available from 7/25/2015 forward)

Earnings

Earnings History for Evotec AG (NASDAQ:EVTCY)
Earnings by Quarter for Evotec AG (NASDAQ:EVTCY)
Earnings History by Quarter for Evotec AG (NASDAQ EVTCY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/28/2017Q4 2016$0.32$47.36 millionViewN/AView Earnings Details
11/10/20169/30/2016($0.02)$0.15$42.79 million$50.41 millionViewN/AView Earnings Details
11/10/2015Q3 2015$0.02($0.04)$37.05 million$36.98 millionViewN/AView Earnings Details
8/12/2015Q2 2015$0.02$0.05$38.43 million$36.97 millionViewN/AView Earnings Details
5/12/2015Q1 2015$0.02($0.02)$24.54 million$24.04 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Evotec AG (NASDAQ:EVTCY)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Evotec AG (NASDAQ:EVTCY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Evotec AG (NASDAQ:EVTCY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Evotec AG (NASDAQ:EVTCY)
Latest Headlines for Evotec AG (NASDAQ:EVTCY)
Source:
DateHeadline
americanbankingnews.com logoZacks: Evotec AG (EVTCY) Given Consensus Rating of "" by Analysts
www.americanbankingnews.com - July 18 at 12:27 AM
americanbankingnews.com logoEvotec AG (EVTCY) Earns Sell Rating from DZ Bank AG
www.americanbankingnews.com - July 12 at 12:44 PM
americanbankingnews.com logo Evotec AG (EVTCY) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - June 29 at 12:48 PM
finance.yahoo.com logoEvotec AG :EVTCY-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017
finance.yahoo.com - June 16 at 3:52 PM
americanbankingnews.com logoEvotec AG (EVTCY) Cut to Hold at Berenberg Bank
www.americanbankingnews.com - June 11 at 3:22 PM
americanbankingnews.com logoZacks: Evotec AG (EVTCY) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - June 9 at 11:00 AM
americanbankingnews.com logoEvotec AG (EVTCY) Stock Rating Reaffirmed by Berenberg Bank
www.americanbankingnews.com - May 20 at 6:56 PM
americanbankingnews.com logo Evotec AG (EVTCY) Given Consensus Rating of "" by Analysts
www.americanbankingnews.com - May 19 at 10:04 AM
finance.yahoo.com logoForge Therapeutics Attracts Biotechnology Leaders To Join Expanded Board Of Directors
finance.yahoo.com - May 16 at 11:50 AM
rttnews.com logoEvotec Turns To Profit In Q1; Backs FY17 Outlook - Quick Facts
www.rttnews.com - May 11 at 3:13 AM
americanbankingnews.com logoEvotec AG (EVTCY) Given Neutral Rating at Deutsche Bank AG
www.americanbankingnews.com - May 3 at 9:06 AM
finance.yahoo.com logoETFs with exposure to Evotec AG : April 7, 2017
finance.yahoo.com - April 7 at 5:02 PM
americanbankingnews.com logo Evotec AG (EVTCY) Receives Average Rating of "Strong Buy" from Brokerages
www.americanbankingnews.com - April 6 at 11:51 AM
americanbankingnews.com logoEvotec AG (EVTCY) Stock Rating Reaffirmed by Deutsche Bank AG
www.americanbankingnews.com - March 31 at 10:26 AM
americanbankingnews.com logoEvotec AG (EVTCY) Rating Reiterated by DZ Bank AG
www.americanbankingnews.com - March 30 at 8:53 AM
nasdaq.com logoEvotec AG FY16 Net Income Rises; Group Revenues Up 29% - Quick Facts
www.nasdaq.com - March 28 at 9:47 PM
americanbankingnews.com logoZacks: Evotec AG (EVTCY) Given Consensus Rating of "" by Brokerages
www.americanbankingnews.com - March 22 at 10:43 AM
nasdaq.com logoEvotec To Invest In Eternygen - Quick Facts
www.nasdaq.com - January 10 at 3:56 AM
nasdaq.com logoEvotec, Celgene Enter Drug Discovery Collaboration
www.nasdaq.com - December 15 at 10:43 PM
nasdaq.com logoEvotec, Forge Therapeutics Form Strategic 'Superbug' Alliance - Quick Facts
www.nasdaq.com - December 9 at 5:22 PM
nasdaq.com logoEvotec Posts Net Profit In Q3; Revenues Climb; Backs FY16 View - Quick Facts
www.nasdaq.com - November 10 at 4:07 PM
nasdaq.com logoEvotec Enters Research Collaboration With Inserm Transfert - Quick Facts
www.nasdaq.com - September 22 at 4:58 PM
finance.yahoo.com logoZacks.com featured highlights: HomeStreet, Horizon Global, Tata Motors, Evotec AG and Liberty Broadband
finance.yahoo.com - September 8 at 4:50 PM
finance.yahoo.com logo7 Stocks with Recent Price Strength Set to Gain Further
finance.yahoo.com - September 7 at 5:05 PM
rttnews.com logoEvotec HY Adj. EBITDA Rises
www.rttnews.com - August 10 at 5:06 PM
seekingalpha.com logoEvotec AG reports Q2 results
seekingalpha.com - August 10 at 6:01 AM
nasdaq.com logoEvotec Stock Up As It Lifts FY16 EBITDA Outlook
www.nasdaq.com - July 19 at 5:02 PM
nasdaq.com logoEvotec Joins With Antibiotic Research UK To Focus On Discovery Of ARBs
www.nasdaq.com - July 11 at 4:55 PM
rttnews.com logoEvotec Shareholders Approve All Proposals
www.rttnews.com - June 15 at 9:40 AM
finance.yahoo.com logoTRIANNI Announces Partnering Agreement with Evotec
finance.yahoo.com - May 17 at 9:51 AM
seekingalpha.com logoEvotec AG reports Q1 results
seekingalpha.com - May 10 at 2:42 AM
seekingalpha.com logoEvotec AG reports FY15 results
seekingalpha.com - March 22 at 6:13 AM
finance.yahoo.com logoEvotec/Spero Deal Extended For Gram-negative Bacteria
finance.yahoo.com - December 16 at 1:20 PM
finance.yahoo.com logoSanofi Teams Up with Google Life Sciences for Diabetes
finance.yahoo.com - September 1 at 4:45 PM
finance.yahoo.com logoSanofi Inks Deals, Diabetes and Immuno-Oncology in Focus
finance.yahoo.com - August 10 at 3:15 PM
finance.yahoo.com logoEvotec Signs New Deal for Addictive Disorder Therapies - Analyst Blog
finance.yahoo.com - January 20 at 6:12 PM

Social

Chart

Evotec AG (EVTCY) Chart for Tuesday, July, 25, 2017

This page was last updated on 7/25/2017 by MarketBeat.com Staff